Providence Sacred Heart Medical Center & Children's Hospital (PSHMC)-Kidney Transplant Program, Spokane, WA 99220, USA.
Am J Health Syst Pharm. 2013 May 15;70(10):900-4. doi: 10.2146/ajhp120254.
Pharmacists' contributions to improved inpatient medication practices and educational services for kidney transplant recipients at a community hospital were evaluated.
A retrospective observational analysis was conducted using demographic and case data collected during the year before (2007) and three years after (2011) the inclusion of pharmacists on the hospital's interdisciplinary kidney transplant team. Qualitative variables assessed included changes in prescribing practices, inpatient and outpatient transplant personnel, discharge planning processes, medication reconciliation, educational practices, and transplant program workflow; quantitative variables included average hospital length of stay (LOS), Scientific Registry of Transplant Recipients data, readmission rates, and reimbursement data. A comparison of data on kidney transplant procedures performed at the hospital in 2007 (n = 60) and 2011 (n = 54) indicated that the implementation of specialized transplant pharmacy services was particularly beneficial in the areas of inpatient medication management, medication reconciliation, discharge planning, and patient education. Program outcomes related to the inclusion of pharmacists on the kidney transplant team included a decrease in the mean LOS among transplant recipients (from 7.8 days in 2007 to 3.4 days in 2011, p < 0.001), with no adverse effect on all-cause 30-, 90-, and >90-day readmission rates (all p > 0.09). Annual cost savings attributable to the reduction in LOS were estimated at $279,180.
The participation of pharmacists on the kidney transplant team enhanced a hospital's medication management, discharge planning, and patient education services for transplant recipients, helping to reduce their average LOS and yielding substantial cost savings.
评估社区医院药剂师在改善住院患者用药实践和为肾移植受者提供教育服务方面的贡献。
采用回顾性观察分析方法,利用 2007 年前(2007 年)和纳入药剂师后三年(2011 年)收集的人口统计学和病例数据进行分析。评估的定性变量包括处方实践、住院和门诊移植人员、出院计划流程、药物重整、教育实践和移植项目工作流程的变化;定量变量包括平均住院时间(LOS)、移植受者科学注册处数据、再入院率和报销数据。对 2007 年(n=60)和 2011 年(n=54)在医院进行的肾移植手术数据进行比较,结果表明,实施专门的移植药房服务特别有利于住院患者的药物管理、药物重整、出院计划和患者教育。与肾移植团队纳入药剂师相关的项目结果包括移植受者的平均 LOS 下降(从 2007 年的 7.8 天降至 2011 年的 3.4 天,p<0.001),但对所有原因 30 天、90 天和>90 天再入院率均无不良影响(均 p>0.09)。据估计,LOS 缩短带来的年度节省成本为 279180 美元。
药剂师参与肾移植团队增强了医院对移植受者的药物管理、出院计划和患者教育服务,有助于降低其平均 LOS 并带来可观的成本节约。